Loading…
Treace Medical Concepts, Inc. is projected to rise to $2.92 by 2027, a +1% move from its current price of $2.90. TMCI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.77 | $2.90 | $3.03 | +0.01% |
| May 30 | $2.72 | $2.90 | $3.09 | +0.02% |
| May 31 | $2.68 | $2.90 | $3.14 | +0.03% |
| Jun 1 | $2.65 | $2.90 | $3.18 | +0.04% |
| Jun 2 | $2.62 | $2.90 | $3.21 | +0.05% |
| Jun 3 | $2.60 | $2.90 | $3.24 | +0.07% |
| Jun 4 | $2.57 | $2.90 | $3.27 | +0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.57 | $2.90 | $3.27 | +0.08% |
| Week 2 | $2.45 | $2.90 | $3.44 | +0.15% |
| Week 3 | $2.36 | $2.91 | $3.58 | +0.23% |
| Week 4 | $2.29 | $2.91 | $3.70 | +0.31% |
| Week 5 | $2.23 | $2.91 | $3.81 | +0.38% |
| Week 6 | $2.17 | $2.91 | $3.91 | +0.46% |
| Week 7 | $2.12 | $2.92 | $4.00 | +0.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Treace Medical Concepts, Inc. is a medical technology company that designs, manufactures, and markets medical devices in the United States.
The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant.
Additionally, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers.
Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Treace Medical Concepts, Inc. (TMCI) is a healthcare stock currently trading at $2.78 with a market cap of $180.35M and a market rank of 3901.
The year-by-year forecast shows a path from 2026 through 2050 with averages of 2026 $2.78, 2027 $2.73, 2028 $2.90, 2029 $3.36, 2030 $3.70, 2031 $4.96, 2032 $5.47, 2033 $4.84, 2034 $4.99, 2035 $5.12, 2040 $8.19, and 2050 $19.57. The forecast also presents bullish sentiment from 2029 onward, with a max forecast by 2050 of $45.01 and a long-run ROI of 604%.
These numbers point to a gradual expansion in value features through the forecast horizon, with stronger upside in the later years. The current price and these projections should be interpreted as estimates, not guarantees, reflecting potential trajectories under the provided assumptions.
A major floor 58.6% below — a decisive break under it would weaken the trend.
The nearest floor, 38.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 25.7% above — clearing it would confirm fresh momentum.
Key TMCI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TMCI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.83 | Buy | $2.82 | Buy |
| MA 10 | $2.76 | Buy | $2.69 | Buy |
| MA 20 | $2.34 | Buy | $2.46 | Buy |
| MA 50 | $1.90 | Buy | $2.16 | Buy |
| MA 100 | $2.02 | Buy | $2.38 | Buy |
| MA 200 | $3.67 | Sell | $3.35 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 73.33 | Sell |
| Stoch RSI (14) | 83.61 | Sell |
| CCI (20) | 89.04 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 44.28 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.82 | Buy |
| Awesome (5,34) | 0.67 | Buy |
| Ultimate (7,14,28) | 78.41 | Sell |
| Momentum (10) | 0.61 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 2.87 | Buy |
| ADX (14) | 32.05 | Buy |
| ATR (14) | 0.09 | Info |
The technical picture is currently neutral with RSI at 70. The stock trades with a 50-day simple moving average of $1.84 and a 200-day simple moving average of $3.70. Support is at $1.78 and resistance at $2.84, framing a modest near-term range.
The 30-day range lies between $2.03 and $3.81, while the current price is $2.78. The neutral sentiment aligns with a cautious near-term view, with potential for movement within the established support/resistance bands as price allocates to the next price discovery window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.20 | $2.90 | $4.16 | 0% | Neutral | |
| $2.17 | $2.92 | $4.23 | +1% | Neutral | |
| $2.18 | $3.09 | $4.73 | +7% | Neutral | |
| $2.46 | $3.63 | $5.80 | +25% | Bullish | |
| $2.65 | $4.06 | $6.71 | +40% | Bullish | |
| $3.34 | $5.30 | $9.04 | +83% | Bullish | |
| $3.59 | $5.88 | $10.30 | +103% | Bullish | |
| $3.17 | $5.35 | $9.62 | +85% | Bullish | |
| $3.12 | $5.44 | $10.00 | +88% | Bullish | |
| $3.14 | $5.64 | $10.58 | +94% | Bullish | |
| $4.35 | $8.99 | $18.37 | +210% | Bullish | |
| $9.79 | $21.77 | $50.06 | +651% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.20 | $2.90 | $3.45 | +0.00% |
| June 2026 | $2.45 | $2.91 | $3.58 | +0.48% |
| July 2026 | $2.42 | $2.93 | $3.68 | +0.52% |
| August 2026 | $2.54 | $3.10 | $3.96 | +5.88% |
| September 2026 | $2.55 | $3.14 | $4.07 | +1.30% |
| October 2026 | $2.41 | $3.00 | $3.94 | -4.44% |
| November 2026 | $2.40 | $3.00 | $3.98 | +0.01% |
| December 2026 | $2.46 | $3.11 | $4.16 | +3.53% |
Click any year to see its month-by-month TMCI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect TMCI to range from $1.20 to $4.16 through 2026. The $2.90 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The TMCI price prediction for 2027 points to an average of $2.92 (low $2.17, high $4.23) — a potential gain of +1% on today's $2.90. A consolidation phase looks the most probable path here.
In 2028, TMCI is projected to trade between $2.18 and $4.73, averaging $3.09 — a potential gain of +7% from today's $2.90. That is up +6% on the projected 2027 average. Price action looks broadly range-bound.
Treace Medical Concepts, Inc.'s 2029 outlook centres on $3.63, within a $2.46 to $5.80 range. That is up +18% on the projected 2028 average. That marks a +25% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, TMCI could reach as high as $6.71, with a base case around $4.06 and support toward $2.65 — roughly +40% from $2.90. Momentum favours further upside here.
Expect TMCI to range from $3.34 to $9.04 through 2031. The $5.30 average target implies a +83% move from current prices. That is up +31% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The TMCI price prediction for 2032 points to an average of $5.88 (low $3.59, high $10.30) — a potential gain of +103% on today's $2.90. Momentum favours further upside here.
In 2033, TMCI is projected to trade between $3.17 and $9.62, averaging $5.35 — a potential gain of +85% from today's $2.90. That is -9% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
Treace Medical Concepts, Inc.'s 2034 outlook centres on $5.44, within a $3.12 to $10.00 range. That is up +2% on the projected 2033 average. That marks a +88% change versus current levels. Momentum favours further upside here.
By 2035, TMCI could reach as high as $10.58, with a base case around $5.64 and support toward $3.14 — roughly +94% from $2.90. Buyers look set to stay in control over this stretch.
Expect TMCI to range from $4.35 to $18.37 through 2040. The $8.99 average target implies a +210% move from current prices. That is up +59% on the projected 2035 average. Momentum favours further upside here.
The TMCI price prediction for 2050 points to an average of $21.77 (low $9.79, high $50.06) — a potential gain of +651% on today's $2.90. Buyers look set to stay in control over this stretch.
Investing $1,000 in TMCI today (≈ 344.827586 TMCI) could be worth
$7,505.44
+$6,505.44 (+651%) by 2050 · US Dollar
Based on the average projected TMCI price of $21.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TMCIwould be worth at today's price.
$1,000 invested in TMCI on May 27, 2025 (≈ 164.203608 TMCI) would be worth
$476.19
-$523.81 (-52.4%) today · 0.48× · US Dollar
Based on a TMCI entry price of $6.09 vs. today's $2.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.82 | $1,028.37 | +2.8% |
| 1 month ago | $1.92 | $1,510.42 | +51.0% |
| 3 months ago | $2.1 | $1,380.95 | +38.1% |
| 6 months ago | $2.98 | $973.15 | -2.7% |
| 1 year ago | $6.09 | $476.19 | -52.4% |
| All time (5.0y) ago | $33.96 | $85.39 | -91.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TMCI forecast.
Our base-case forecast reaches $5.80 around 2032.
Implied market cap at $5.80: $376.26M
Over the multi-year horizon, the forecast shows a bullish shift beginning in 2029, with 2029 avg $3.36 and ROI 21%, rising to 2030 avg $3.70 and ROI 33%. The 2040 forecast strengthens to avg $8.19 with ROI 194.7%, and the 2050 projection climbs to avg $19.57 with ROI 604% and max $45.01. The sentiment remains BULLISH from 2029 onward, signaling sustained upside potential through 2050.
Key mid- decade milestones include 2031 avg $4.96 (ROI 78.4%), 2032 avg $5.47 (ROI 96.7%), and 2033 avg $4.84 (ROI 74.2%), followed by continued growth in 2034–2035. By 2040, the blend of higher averages and bullish sentiment supports a markedly higher trajectory, culminating in the 2050 peak figures. These are estimates, not guarantees, and depend on the underlying assumptions of the forecast.
Tap a question to reveal the answer.
The 2030 forecast shows min $2.37, avg $3.70, max $6.22 with ROI 33% and sentiment BULLISH.
The forecast assigns a BULLISH sentiment from 2029 onward, with 2030 avg $3.70, 2040 avg $8.19, and 2050 avg $19.57, plus a max of $45.01 and ROI up to 604%.
The 2040 forecast max is $17.13, with an average of $8.19 and min $3.79; the 2050 outlook shows higher potential, up to $45.01.
Current price is $2.78 and market cap is $180.35M.
2050 min $8.81, avg $19.57, max $45.01, ROI 604, sentiment BULLISH.
Treace Medical Concepts, Inc. Community Discussion
0Share your Treace Medical Concepts, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.